Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
1,200 rows where in_cev_map = 0, surface_class = "B_cargo" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
tier 1
- Tier 1.5 · 1,200 ✖
surface_class 1
- B_cargo · 1,200 ✖
in_cev_map 1
- - · 1,200 ✖
has_activation_state_pdb_pair 1
- 0 1,200
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P22304 | IDS | Iduronate 2-sulfatase | Tier 1.5 | 0.613 | 1 | B_cargo | 2 | 93.06 | 0 | 0 | 1 | 9 | 41791433, 41521476, 41396069, 40394224, 37948569, 31273548, 30529550, 28420169, 20842131 | 0 | mucopolysaccharidosis type 2 | 0.8781523206667287 | ||
| Q8NCM8 | DYNC2H1 | Cytoplasmic dynein 2 heavy chain 1 | Tier 1.5 | 0.608 | 1 | B_cargo | 4 | 83.44 | 1 | 0 | 0 | 0 | 0 | asphyxiating thoracic dystrophy 3 | 0.8610362911667925 | |||
| O76039 | CDKL5 | Cyclin-dependent kinase-like 5 | Tier 1.5 | 0.605 | 1 | B_cargo | 3 | 53.12 | 0 | 0 | 0 | 0 | 0 | developmental and epileptic encephalopathy, 2 | 0.8510325653635987 | |||
| Q9UIF7 | MUTYH | Adenine DNA glycosylase | Tier 1.5 | 0.605 | 1 | B_cargo | 3 | 78.94 | 0 | 0 | 0 | 0 | 0 | familial adenomatous polyposis 2 | 0.8483469680730393 | |||
| Q2M1P5 | KIF7 | Kinesin-like protein KIF7 | Tier 1.5 | 0.603 | 1 | B_cargo | 5 | 67.19 | 1 | 0 | 0 | 0 | 0 | acrocallosal syndrome | 0.8424257475739304 | |||
| O60931 | CTNS | Cystinosin | Tier 1.5 | 0.603 | 1 | B_cargo | 6 | 89.44 | 1 | 0 | 0 | 0 | 0 | nephropathic cystinosis | 0.841818398377195 | |||
| P58012 | FOXL2 | Forkhead box protein L2 | Tier 1.5 | 0.603 | 1 | B_cargo | 2 | 60.12 | 0 | 0 | 1 | 1 | 37933840 | 0 | blepharophimosis, ptosis, and epicanthus inversus syndrome | 0.841709236718747 | ||
| P20823 | HNF1A | Hepatocyte nuclear factor 1-alpha | Tier 1.5 | 0.602 | 1 | B_cargo | 6 | 56.97 | 0 | 0 | 1 | 4 | 15781225, 15629461 | 0 | MODY | 0.8405262466243777 | ||
| P38935 | IGHMBP2 | DNA-binding protein SMUBP-2 | Tier 1.5 | 0.602 | 1 | B_cargo | 4 | 77.38 | 0 | 0 | 0 | 0 | 0 | autosomal recessive distal spinal muscular atrophy 1 | 0.8396147647161344 | |||
| Q9HBG6 | IFT122 | Intraflagellar transport protein 122 homolog | Tier 1.5 | 0.602 | 1 | B_cargo | 5 | 82.88 | 1 | 0 | 0 | 0 | 0 | cranioectodermal dysplasia | 0.8402296001002503 | |||
| O43435 | TBX1 | T-box transcription factor TBX1 | Tier 1.5 | 0.602 | 1 | B_cargo | 1 | 68.19 | 0 | 0 | 1 | 1 | 24797903 | 0 | 22q11.2 deletion syndrome | 0.8406035626999856 | ||
| P82279 | CRB1 | Protein crumbs homolog 1 | Tier 1.5 | 0.602 | 1 | B_cargo | 1 | 75.06 | 0 | 0 | 0 | 0 | 0 | Leber congenital amaurosis 8 | 0.8398871782775204 | |||
| Q8N159 | NAGS | N-acetylglutamate synthase, mitochondrial | Tier 1.5 | 0.601 | 1 | B_cargo | 1 | 79.75 | 0 | 0 | 0 | 0 | 0 | hyperammonemia due to N-acetylglutamate synthase deficiency | 0.8382373711482316 | |||
| Q2TBA0 | KLHL40 | Kelch-like protein 40 | Tier 1.5 | 0.6 | 1 | B_cargo | 1 | 89.44 | 0 | 0 | 0 | 0 | 0 | nemaline myopathy 8 | 0.8348979900805442 | |||
| Q9BXW9 | FANCD2 | Fanconi anemia group D2 protein | Tier 1.5 | 0.6 | 1 | B_cargo | 13 | 76.75 | 1 | 0 | 0 | 0 | 0 | Fanconi anemia complementation group D2 | 0.8319139646572291 | |||
| Q05066 | SRY | Sex-determining region Y protein | Tier 1.5 | 0.599 | 1 | B_cargo | 10 | 67.62 | 1 | 0 | 1 | 1 | 40082426 | 0 | 46,XY sex reversal 1 | 0.8290523705747719 | ||
| P31271 | HOXA13 | Homeobox protein Hox-A13 | Tier 1.5 | 0.598 | 1 | B_cargo | 1 | 54.28 | 0 | 0 | 0 | 0 | 0 | hand-foot-genital syndrome | 0.8270145658663097 | |||
| Q13485 | SMAD4 | SMAD family member 4 | Tier 1.5 | 0.598 | 1 | B_cargo | 12 | 73.38 | 0 | 0 | 1 | 10 | 39602246, 35356877, 33124760, 32456365, 31876518, 29632714, 27843907, 21266541, 17132729, 16775010 | 0 | juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | 0.8277625447220475 | ||
| Q99593 | TBX5 | T-box transcription factor TBX5 | Tier 1.5 | 0.598 | 1 | B_cargo | 4 | 62.66 | 0 | 0 | 0 | 0 | 0 | Holt-Oram syndrome | 0.827317913681364 | |||
| P13686 | ACP5 | Tartrate-resistant acid phosphatase type 5 | Tier 1.5 | 0.597 | 1 | B_cargo | 2 | 94.62 | 0 | 0 | 1 | 2 | 30537181 | 0 | Spondyloenchondrodysplasia with immune dysregulation | 0.8234579245679164 | ||
| Q96GM8 | TOE1 | Target of EGR1 protein 1 | Tier 1.5 | 0.597 | 1 | B_cargo | 1 | 77.75 | 0 | 0 | 0 | 0 | 0 | pontocerebellar hypoplasia type 7 | 0.824632140055663 | |||
| Q9BYX4 | IFIH1 | Interferon-induced helicase C domain-containing protein 1 | Tier 1.5 | 0.597 | 1 | B_cargo | 9 | 79.44 | 1 | 0 | 1 | 1 | 18983163 | 0 | Aicardi-Goutieres syndrome 7 | 0.8235229759148853 | ||
| Q9UH77 | KLHL3 | Kelch-like protein 3 | Tier 1.5 | 0.597 | 1 | B_cargo | 3 | 90.5 | 0 | 0 | 0 | 0 | 0 | pseudohypoaldosteronism type 2D | 0.8246213773832068 | |||
| P28069 | POU1F1 | Pituitary-specific positive transcription factor 1 | Tier 1.5 | 0.596 | 1 | B_cargo | 1 | 67.75 | 0 | 0 | 0 | 0 | 0 | pituitary hormone deficiency, combined, 1 | 0.8206947239178665 | |||
| Q99453 | PHOX2B | Paired mesoderm homeobox protein 2B | Tier 1.5 | 0.596 | 1 | B_cargo | 5 | 59.78 | 0 | 0 | 0 | 0 | 0 | central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease | 0.8208322275185037 | |||
| Q9H334 | FOXP1 | Forkhead box protein P1 | Tier 1.5 | 0.596 | 1 | B_cargo | 1 | 57.94 | 0 | 0 | 0 | 0 | 0 | intellectual disability-severe speech delay-mild dysmorphism syndrome | 0.8203183311387787 | |||
| O15259 | NPHP1 | Nephrocystin-1 | Tier 1.5 | 0.594 | 1 | B_cargo | 2 | 75.88 | 0 | 0 | 0 | 0 | 0 | nephronophthisis 1 | 0.8140254888983035 | |||
| Q53S33 | BOLA3 | BolA-like protein 3 | Tier 1.5 | 0.594 | 1 | B_cargo | 1 | 80.94 | 0 | 0 | 0 | 0 | 0 | multiple mitochondrial dysfunctions syndrome 2 | 0.8146596253409263 | |||
| P41229 | KDM5C | Lysine-specific demethylase 5C | Tier 1.5 | 0.594 | 1 | B_cargo | 2 | 71.94 | 0 | 0 | 0 | 0 | 0 | syndromic X-linked intellectual disability Claes-Jensen type | 0.8149829731199962 | |||
| P04198 | MYCN | N-myc proto-oncogene protein | Tier 1.5 | 0.593 | 1 | B_cargo | 2 | 60.16 | 0 | 0 | 1 | 3 | 38074684, 34703655, 23243020 | 0 | Feingold syndrome type 1 | 0.8115451687313872 | ||
| Q8IXJ9 | ASXL1 | Polycomb group protein ASXL1 | Tier 1.5 | 0.592 | 1 | B_cargo | 4 | 42.22 | 1 | 0 | 0 | 0 | 0 | Bohring-Opitz syndrome | 0.8082443730060624 | |||
| Q9BSI4 | TINF2 | TERF1-interacting nuclear factor 2 | Tier 1.5 | 0.592 | 1 | B_cargo | 3 | 60.56 | 0 | 0 | 0 | 0 | 0 | dyskeratosis congenita, autosomal dominant 3 | 0.8076730158243078 | |||
| Q9NW38 | FANCL | E3 ubiquitin-protein ligase FANCL | Tier 1.5 | 0.592 | 1 | B_cargo | 8 | 91.31 | 1 | 0 | 0 | 0 | 0 | Fanconi anemia complementation group L | 0.8062585405338945 | |||
| P51530 | DNA2 | DNA replication ATP-dependent helicase/nuclease DNA2 | Tier 1.5 | 0.591 | 1 | B_cargo | 1 | 87.81 | 0 | 0 | 1 | 79 | 41919953, 40756646, 40549055, 40280078, 40067128, 39933341, 39701233, 39400726, 39339485, 39263860, 39196429, 38844882, 38240894, 38219326, 38057050, 38015452, 37991343, 37955623, 37604608, 37499488, 37470836, 36958207, 36809725, 36242904, 36178489, 36150338, 35491044, 35384954, 35176850, 35093773, 33676715, 33496853, 33415103, 33217231, 32800122, 32601890, 32475386, 32200901, 31706177, 31561796, 31278549, 31276907, 31159934, 30952252, 30904620, 30862445, 30609356, 30209628, 30172325, 29884355 | 0 | mitochondrial DNA deletion syndrome with progressive myopathy | 0.8039462281320306 | ||
| Q9NRG9 | AAAS | Aladin | Tier 1.5 | 0.59 | 1 | B_cargo | 2 | 75.25 | 1 | 0 | 1 | 2 | 39798364, 30768874 | 0 | triple-A syndrome | 0.8009946434571534 | ||
| P17735 | TAT | Tyrosine aminotransferase | Tier 1.5 | 0.59 | 1 | B_cargo | 1 | 91.75 | 0 | 0 | 1 | 116 | 42052694, 41392711, 41107360, 41026857, 40789888, 40681131, 40125796, 40063097, 39876991, 39558155, 39335496, 39318271, 39167715, 38924638, 38501479, 38054213, 37240414, 36879476, 36832059, 36642821, 36576612, 36475447, 36277654, 36209487, 36198145, 35654302, 35364795, 33981364, 33909408, 33155468, 33149582, 32976590, 32250590, 32147886, 32100315, 32061015, 32051269, 31975549, 31881749, 31880928, 31707021, 35345244, 31243610, 30976173, 30540162, 30529550, 30350592, 30285239, 30198708, 29464116 | 0 | tyrosinemia type II | 0.7986496109306669 | ||
| P46020 | PHKA1 | Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | Tier 1.5 | 0.589 | 1 | B_cargo | 10 | 81.69 | 1 | 0 | 0 | 0 | 0 | glycogen storage disease IXd | 0.7957863874816654 | |||
| Q8WX94 | NLRP7 | NACHT, LRR and PYD domains-containing protein 7 | Tier 1.5 | 0.589 | 1 | B_cargo | 3 | 82.25 | 1 | 0 | 0 | 0 | 0 | hydatidiform mole, recurrent, 1 | 0.7978415742308576 | |||
| Q9ULV5 | HSF4 | Heat shock factor protein 4 | Tier 1.5 | 0.589 | 1 | B_cargo | 2 | 59.59 | 0 | 0 | 0 | 0 | 0 | cataract 5 multiple types | 0.7953462784936949 | |||
| O60281 | ZNF292 | Zinc finger protein 292 | Tier 1.5 | 0.588 | 1 | B_cargo | 2 | 46.91 | 0 | 0 | 0 | 0 | 0 | intellectual developmental disorder, autosomal dominant 64 | 0.7931698496364843 | |||
| Q9UBR1 | UPB1 | Beta-ureidopropionase | Tier 1.5 | 0.588 | 1 | B_cargo | 2 | 97.0 | 1 | 0 | 0 | 0 | 0 | beta-ureidopropionase deficiency | 0.7918900848494692 | |||
| O14770 | MEIS2 | Homeobox protein Meis2 | Tier 1.5 | 0.588 | 1 | B_cargo | 4 | 61.97 | 0 | 0 | 1 | 2 | 41495882 | 0 | cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies | 0.7938323593532864 | ||
| Q00973 | B4GALNT1 | Beta-1,4 N-acetylgalactosaminyltransferase 1 | Tier 1.5 | 0.588 | 1 | B_cargo | 3 | 88.69 | 0 | 0 | 0 | 0 | 0 | hereditary spastic paraplegia 26 | 0.7949291425747776 | |||
| P19532 | TFE3 | Transcription factor E3 | Tier 1.5 | 0.587 | 1 | B_cargo | 1 | 58.66 | 0 | 0 | 0 | 0 | 0 | intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies | 0.7894865093321197 | |||
| Q9Y2M0 | FAN1 | Fanconi-associated nuclease 1 | Tier 1.5 | 0.587 | 1 | B_cargo | 18 | 69.88 | 1 | 0 | 0 | 0 | 0 | karyomegalic interstitial nephritis | 0.7887103269780822 | |||
| P81274 | GPSM2 | G-protein-signaling modulator 2 | Tier 1.5 | 0.587 | 1 | B_cargo | 7 | 66.94 | 0 | 0 | 0 | 0 | 0 | Chudley-McCullough syndrome | 0.7892319521351122 | |||
| A6NGG8 | PCARE | Photoreceptor cilium actin regulator | Tier 1.5 | 0.586 | 1 | B_cargo | 1 | 43.78 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.7851829492847434 | |||
| O15119 | TBX3 | T-box transcription factor TBX3 | Tier 1.5 | 0.586 | 1 | B_cargo | 1 | 54.91 | 0 | 0 | 1 | 1 | 34873487 | 0 | ulnar-mammary syndrome | 0.7856453214934344 | ||
| Q6PJG6 | BRAT1 | Integrator complex assembly factor BRAT1 | Tier 1.5 | 0.586 | 1 | B_cargo | 5 | 84.81 | 1 | 0 | 0 | 0 | 0 | Lethal neonatal spasticity-epileptic encephalopathy syndrome | 0.7870801460315344 | |||
| O15409 | FOXP2 | Forkhead box protein P2 | Tier 1.5 | 0.585 | 1 | B_cargo | 2 | 59.22 | 0 | 0 | 0 | 0 | 0 | childhood apraxia of speech | 0.7839103460347123 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;